Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARFILZOMIB vs CARIPRAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARFILZOMIB vs CARIPRAZINE: Safety Overview

Metric CARFILZOMIB CARIPRAZINE
Total FAERS Reports 21,814 6,547
Deaths Reported 3,448 194
Death Rate 15.8% 3.0%
Hospitalizations 7,502 702
Average Patient Age 64.7 yrs 40.4 yrs
% Female Patients 42.6% 64.0%
FDA Approval Date Jul 20, 2012 Dec 16, 2025
Manufacturer Onyx Pharmaceuticals, Inc. Allergan, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription